Clinical Trials
4 trialsNCT03131037 2025-07-11
Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Candel Therapeutics, Inc.
Phase 1 Completed
NCT03004183 2024-10-15
STOMP
The Methodist Hospital Research Institute
Phase 2 Completed
NCT02831933 2023-09-21
ENSIGN
The Methodist Hospital Research Institute
Phase 2 Terminated
NCT01997190 2023-08-25
MpeTK01
Candel Therapeutics, Inc.
Phase 1 Completed